Copertina

Multi‐omics integration analysis identifies INPP4B as a T‐cell‐specific activation suppressor

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ting Peng, Qing Fang, Zihao Zhao, Yingjun Chang, Xiangyu Zhao, Cheng Li
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Clinical and Translational Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer
di: Yifan Cao, et al.
Pubblicazione: (2024)

Multi‐omics analysis of pyroptosis‐related genes for prognosis and immune landscape in head and neck cancer
di: Shikang Zheng, et al.
Pubblicazione: (2024)

Multi‐omics profiling identifies TNFRSF18 as a novel marker of exhausted CD8⁺ T cells and reveals tumour‐immune dynamics in colorectal cancer
di: Tengfei Jia, et al.
Pubblicazione: (2025)

Multi‐omics analysis revealed biomarkers for coronary atherosclerosis: Occurrence and development
di: Mengxue He, et al.
Pubblicazione: (2025)

Single‐cell and spatial omics unravel the spatiotemporal biology of tumour border invasion and haematogenous metastasis
di: Xifu Cheng, et al.
Pubblicazione: (2024)

Multi‐omics reveals a novel Cxcr4 + subpopulation of alveolar macrophages and therapeutic effect of AMD3100 in mice with advanced silicosis
di: Min Mu, et al.
Pubblicazione: (2026)

Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer‐related gene in pancreatic cancer
di: Mengge Li, et al.
Pubblicazione: (2025)

Single‐cell multi‐omics analysis of the tumour microenvironment for colorectal cancer liver metastasis
di: Jiao Guan, et al.
Pubblicazione: (2026)

Multi‐omics molecular phenotyping reveals the potential mechanisms of chemotherapy response and resistance in small cell lung cancer
di: Ying Cheng, et al.
Pubblicazione: (2024)

Integrating multi‐omics features enables non‐invasive early diagnosis and treatment response prediction of diffuse large B‐cell lymphoma
di: Weilong Zhang, et al.
Pubblicazione: (2025)

Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment
di: Xiaoqiang Wang, et al.
Pubblicazione: (2024)

Adipocyte‐specific FAK deletion promotes pancreatic β‐cell apoptosis via adipose inflammatory response to exacerbate diabetes mellitus
di: Fei Ding, et al.
Pubblicazione: (2024)

Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer
di: Haoran Li, et al.
Pubblicazione: (2024)

Pan‐cancer multi‐omics reveals DCAF7 as an immune‐modulating prognostic driver and Wnt/β‐catenin activator in hepatocellular carcinoma
di: Ruina Luan, et al.
Pubblicazione: (2025)

Predictive nomogram integrating radiomics and multi‐omics for improved prognosis‐model in cholangiocarcinoma
di: Yunlu Jia, et al.
Pubblicazione: (2025)

Dissecting cross‐lineage tumourigenesis under p53 inactivation through single‐cell multi‐omics and spatial transcriptomics
di: Xinru Wang, et al.
Pubblicazione: (2025)

Comprehensive pan‐cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance
di: Qingshan Chen, et al.
Pubblicazione: (2024)

Cancer therapy resistance from a spatial‐omics perspective
di: Yinghao Zhang, et al.
Pubblicazione: (2025)

Multi‐omics predictive model based on clinical, radiomic and genomic features for predicting the response of limited‐stage small cell lung cancer to definitive chemoradiotherapy
di: Li Li, et al.
Pubblicazione: (2024)

B‐cell performance in chemotherapy: Unravelling the mystery of B‐cell therapeutic potential
di: Zizhuo Li, et al.
Pubblicazione: (2024)

Natural killer cell engagers: From bi‐specific to tri‐specific and tetra‐specific engagers for enhanced cancer immunotherapy
di: An Zhu, et al.
Pubblicazione: (2024)

Integrative multiomics analysis identifies molecular subtypes and potential targets of hepatocellular carcinoma
di: Shuai Yang, et al.
Pubblicazione: (2024)

Multi‐omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy
di: Nils C. H. van Creij, et al.
Pubblicazione: (2026)

Integrated multi‐omics profiling landscape of organising pneumonia
di: Ying Tang, et al.
Pubblicazione: (2024)

Baseline multi‐omics signatures could predict therapeutic response to neoadjuvant anti‐PD‐1 immunochemotherapy in non‐small‐cell lung cancer
di: Ailing Cao, et al.
Pubblicazione: (2026)

Integrated spatial multi‐omics profiling of Fusobacterium nucleatum in breast cancer unveils its role in tumour microenvironment modulation and cancer progression
di: Feng Zhao, et al.
Pubblicazione: (2025)

Envisioning population‐scale immune multi‐omics atlas projects
di: Yuhui Zheng, et al.
Pubblicazione: (2026)

Spatial omics strategies for investigating human carotid atherosclerotic disease
di: Jiaxin Wan, et al.
Pubblicazione: (2025)

Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
di: Lihaoyun Huang, et al.
Pubblicazione: (2024)

Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer
di: Sally E. Claridge, et al.
Pubblicazione: (2025)

Single‐cell and spatial transcriptomics uncover neoadjuvant chemotherapy‐resistant malignant cells with inhibitory signalling on B cells in gastric cancer
di: Pei‐Yi Han, et al.
Pubblicazione: (2026)

HBx hijacks the miR‐19a‐3p/BAMBI/TGF‐β1 axis to impair the anti‐tumour activity of CD4 + T cells in diffuse large B‐cell lymphoma
di: Xuecong Guo, et al.
Pubblicazione: (2026)

Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study
di: Rong Shen, et al.
Pubblicazione: (2025)

Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trial
di: Yuzhou Zhao, et al.
Pubblicazione: (2024)

Single‐cell transcriptomics reveal circulating skin‐homing CLA + CTSW + cytotoxic CD4 + T cells contribute to relapse of psoriasis
di: Hsien‐Yi Chiu, et al.
Pubblicazione: (2025)

Predictive medicine in a testis trio‐family through a combined multi‐omics approach
di: Federica Di Maggio, et al.
Pubblicazione: (2024)

Commentary: Molecular responses in pig heart to human xenotransplantation unveiled by longitudinal multi‐omic profiling
di: Brendan J. Keating, et al.
Pubblicazione: (2025)

ATG16L1 restrains macrophage NLRP3 activation and alveolar epithelial cell injury during septic lung injury
di: Yan Bai, et al.
Pubblicazione: (2025)

PIWI‐interacting RNA MIABEPIR regulates cerebral endothelial cell function via DAPK2 pathway in offspring following maternal immune activation
di: Shan‐Shan Li, et al.
Pubblicazione: (2025)

Machine learning‐based multi‐omics models for diagnostic classification and risk stratification in diabetic kidney disease
di: Xian Shao, et al.
Pubblicazione: (2025)